Skip to main content

Showing results for Faculty

IU School of Medicine names first Walther Scholar in Psycho-Oncology

Indiana University School of Medicine has named Shelley Johns, PsyD, ABPP, the Walther Scholar in Psycho-Oncology.

IU School of Medicine  |  Apr 26, 2022

IU School of Medicine names new chair to lead Department of Surgery

Karl Bilimoria, MD, MS, FACS, has been named the new chair of the Department of Surgery. A highly respected physician-scientist in the field of surgical oncology and author of more than 400 publications with nearly $40 million in research funding, Bilimoria graduated from IU School of Medicine in 2003. He is currently a surgical oncologist at Northwestern Medicine in Chicago, also serving as a professor of surgery and vice chair for quality in the Department of Surgery at the Northwestern University Feinberg School of Medicine. 

IU School of Medicine  |  Apr 11, 2022

IU School of Medicine faculty named IBJ Forty Under 40 honorees

Two Indiana University School of Medicine faculty have been named 2022 Indianapolis Business Journal Forty Under 40 honorees. Lana Dbeibo, MD and Kenneth Lim, MD, PhD were chosen for the prestigious honor.

Christina Griffiths  |  Mar 25, 2022

Cardiovascular Institute and Department of Medicine recruits signal a future of equity and innovation in cardiovascular medicine

Two widely recognized leaders in cardiovascular medicine have been recruited to the Cardiovascular Institute (CVI), a joint enterprise between Indiana University School of Medicine Department of Medicine and Indiana University Health on the forefront of cardiovascular care, research and education.

IU School of Medicine  |  Feb 03, 2022

Stone Center for Child and Adolescent Psychiatry names inaugural executive director

Indiana University School of Medicine has named its first executive director of the recently announced Mary O’Daniel Stone and Bill Stone Center for Child and Adolescent Psychiatry at IU School of Medicine—Evansville. 

IU School of Medicine  |  Jan 19, 2022

IU School of Medicine research provides advances in treatment of triple negative breast cancer

Indiana University School of Medicine physician scientist Bryan Schneider, MD is the principal investigator of clinical trial BRE12-158, a randomized clinical study published in the prominent Journal of Clinical Oncology the primary goal of which was to compare survival in women with high-risk (those who did not fully respond to chemotherapy prior to surgery) triple negative breast cancer (TNBC) with a genomically directed therapy versus standard of care.

IU School of Medicine  |  Dec 15, 2021

Regenerative medicine researcher Chandan Sen, PhD, elected to National Academy of Inventors

Chandan K. Sen, PhD, director of the Indiana Center for Regenerative Medicine and Engineering at Indiana University School of Medicine has been elected as a fellow of the National Academy of Inventors. 

IU School of Medicine  |  Dec 07, 2021

IU cancer researcher leads national work focused on developing treatments for inherited childhood cancers

An Indiana University cancer researcher is leading an $11.4 million grant from the National Cancer Institute in which he and others across the country will work on identifying new treatments for tumors that develop in children, adolescents and adults with a common genetic condition.

IU School of Medicine  |  Nov 18, 2021

IU Simon Comprehensive Cancer Center names its first associate director of diversity, equity and inclusion

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has named Antwione Haywood, PhD, its associate director of diversity, equity and inclusion (DEI). Haywood is the first person to hold the chief diversity officer position at the cancer center. 

IU School of Medicine  |  Oct 18, 2021

IU School of Medicine researchers discover ties between COVID-19 and bone loss

Researchers in the Department of Orthopaedic Surgery at Indiana University School of Medicine have discovered that SARS-CoV-2 can cause quick and significant bone loss—even when infections are mild.

IU School of Medicine  |  Oct 05, 2021